IGI Logo

Below the Quote on US - India Trade Deal - Sushil Suri, CMD at Morepen Labs

"We welcome the drastic cut in trade tariffs, which helps end uncertainty and ambiguity and paves the way for deeper, long-term engagement between two large and highly compatible economies. India is the pharmacy of the world, supplying nearly 47% of all generic medicines consumed in the United States — a testament to the strength of the existing India–US healthcare partnership. India is not going global; India is already global. With the Union Budget’s continued focus on healthcare, manufacturing and innovation, this renewed momentum further strengthens collaboration across generics, advanced contract manufacturing and biotechnology research, reinforcing resilient global healthcare supply chains.”

Above views are of the author and not of the website kindly read disclaimer